Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
PepsiCo announced on Tuesday that it has agreed to buy Siete Foods for $1.2 billion, another food M&A deal this year.
Boeing is considering an emergency move: selling $10 billion in new stock to score some quick cash amid a union strike.
News Corp subsidiary REA Group abandoned its monthlong quest to take control of Rightmove, which rejected four “unattractive” bids.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
The e-commerce and media titan is in talks with veteran TV news anchor Brian Williams to host an election night special, Variety reported.
Dallas-based Steward Health Care is may just well be the poster child for private equity investment in healthcare gone wrong.
Saudi Arabia, the biggest and most influential member of OPEC, is abandoning its goal of driving the price of an oil barrel up to $100.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
The Biden administration is introducing a ban on both hardware and software for “connected vehicles” from China and, incidentally, Russia.
A group of 14 large banks and other financial institutions announced that they’re going to up their support for the nuclear power industry.
The International Longshoremen’s Association is set to strike if a new contract can’t be reached with the United States Maritime Alliance.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.